Trutina Financial’s AbbVie ABBV Stock Holding History

Trutina Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,000	Closed	-$51K	–	69
2014 Q1	$51K	Buy	+1,000	New	+$50.5K	0.04%	119
2013 Q4	–	Sell	-300	Closed	-$13K	–	73
2013 Q3	$13K	Buy	+300	New	+$13.3K	0.01%	174

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Trutina Financial's ABBV Position: Q2 2014 in Review

Trutina Financial sold out of AbbVie (ABBV) in Q2 2014, closing a stake of 1,000 shares — an estimated $51K sold.

Trutina Financial first reported a position in ABBV in Q3 2013 and held it in 2 quarters. The position peaked at $51K in Q1 2014. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

Trutina Financial reported no remaining AbbVie position as of Q2 2014 after selling out during the quarter.
Trutina Financial sold 1,000 AbbVie shares in Q2 2014, an estimated $51K.
Trutina Financial first reported a position in AbbVie in Q3 2013 and held it in 2 quarters.
Trutina Financial's AbbVie position peaked at $51K in Q1 2014.
1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Trutina Financial's 13F filing for Q2 2014, filed 14 Aug 2014.